Adial Pharmaceuticals Announces Pricing of Initial Public Offering
27 juil. 2018 07h00 HE
|
Adial Pharmaceutical, Inc.
CHARLOTTESVILLE, Va., July 27, 2018 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) (NASDAQ:ADILW), a clinical-stage biopharmaceutical company focused on the development of a...